👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
Trust score 8/100
Accepting new patients
Dr
Dr Angela George
Oncology
English
9,802+
Patients seen
6
Years in practice
8
Publications
1
Languages spoken
About
Dr Angela George is a Consultant Medical Oncologist and Consultant in Oncogenetics. Dr George specialises in the systemic treatment of gynaecological cancers and has a particular focus on the use of genomic information in treatment. Dr George is involved in multiple national and international groups, including the National Cancer Research Institute Gynaecological Cancers Group, the Precision Medicine working group for the European Society of Medical Oncology and the British Society of Genetic Medicine. They are also the Cancer Clinical Lead for the North London Genomic Medicine Service and co-chairs the molecular tumour board. Dr George has authored multiple peer-reviewed publications and undertakes research into the genetics of ovarian and breast cancer.
Dr George completed their specialty training in Medical Oncology in New Zealand and began as a Consultant Medical Oncologist with a particular interest in ovarian and breast cancer. They subsequently moved to The Royal Marsden Hospital, where they worked in the Gynaecology unit, then began research into the germline genetics of ovarian cancer. During this time, they led the implementation of the Mainstreaming Cancer Genetics programme within the Gynaecology and Breast units. After completion of their thesis, they were appointed as a Consultant in Oncogenetics and Medical Oncologist (Gynaecology) at The Royal Marsden. In addition to their work in the Gynaecology Unit, they are Clinical Lead for Cancer Genetics and the Mainstreaming Cancer Genetics programme and Clinical Director of Genomics at The Royal Marsden. They are also continuing their research into the genetics of ovarian and breast cancer.
Dr George completed their specialty training in Medical Oncology in New Zealand and began as a Consultant Medical Oncologist with a particular interest in ovarian and breast cancer. They subsequently moved to The Royal Marsden Hospital, where they worked in the Gynaecology unit, then began research into the germline genetics of ovarian cancer. During this time, they led the implementation of the Mainstreaming Cancer Genetics programme within the Gynaecology and Breast units. After completion of their thesis, they were appointed as a Consultant in Oncogenetics and Medical Oncologist (Gynaecology) at The Royal Marsden. In addition to their work in the Gynaecology Unit, they are Clinical Lead for Cancer Genetics and the Mainstreaming Cancer Genetics programme and Clinical Director of Genomics at The Royal Marsden. They are also continuing their research into the genetics of ovarian and breast cancer.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Angela George
Education & training
-
2010–2016 MD · Medicine and Surgery
-
2016–2020 Residency · Oncology
-
2020–2021 Fellowship · Subspecialty training
Career & appointments
-
2020-09–2021-08 Junior consultant
Licenses & insurance
Medical licenses
— Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
AXA Healthcare Liability · 2,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 621 |
| Annual physical exam | 99395 | 1,723 |
| Vaccination administration | 90471 | 1,467 |
| Minor procedure (skin) | 17110 | 2,004 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 450.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 180.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 11 · i10: 5
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.9225/euroclin.2025.0 · PMID: 33045073 · cited by 141
-
European registry analysis of Oncology outcomes
DOI: 10.2013/euroclin.2024.1 · PMID: 37589561 · cited by 71
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2021
- national college of family doctors — Member · since 2021
- European Union of Medical Specialists (UEMS) — Member · since 2021
Patient reviews
- Bedside Manner
- 0.05
- Knowledge
- 0.08
- Wait Time
- 3.80
- Staff Friendliness
- 0.02
- Ease Of Appointment
- 4.00
- Value For Money
- 4.10
- Would Recommend Pct
- 4
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · angela.george@euroclinics.example
